Surrey’s new £1m clinical research facility to tackle serious illness and diseases in the South East
News | 11-03-2022
Research in the South East of England has been given a £1m boost to find new treatments for a range of serious illnesses including cancer, diabetes, digestive and liver diseases.
The National Institute for Health Research (NIHR) has awarded £1m to the University of Surrey and Royal Surrey NHS Foundation Trust to form a new NIHR Clinical Research Facility called the NIHR Royal Surrey Clinical Research Facility (CRF). The state-of-the-art facility will be based at the University’s Manor Park campus, adjacent to Royal Surrey Hospital.
Professor Paul Townsend, Pro-Vice-Chancellor and Executive Dean of the University’s Faculty of Health and Medical Sciences, said:
“The world of medicine is changing, and I firmly believe that the use of technology and data will be instrumental to improving health outcomes for people in the south-east and nationwide. The new Surrey Clinical Research Facility will be a hub for creative clinical thinking and a shining example of the University of Surrey’s ‘One Health, One Medicine’ approach.”
The facility will expand the shared medical research capabilities of the hospital and university, providing dedicated space, specialist equipment and skilled staff to support early-stage clinical research, including first-in-human clinical trials.
Research studies are expected to cover a broad range of specialities including cancer, diabetes, endocrinology, ophthalmology, genetic rare diseases, neurology, immunology, digestive and liver diseases, artificial intelligence (AI), robotic surgery and nuclear medicine. There will be a strong focus on supporting equity of access to patients including those from marginalised and underrepresented communities.
Back To All